The Antimicrobial Advocate, Volume 3, Issue 5-6
Highlights from this issue:
- Tebipenem FDA approval
- Guidance for AS Program Leaders
- Review of C. auris
- Cefazolin vs. Antistaphylococcal Penicillins for MSSA Bacteremia
- Educational opportunities



